Frontlight ResearchEarly access
Taking people in SpainPhase 4
Tests heated mitomycin-C before bladder tumor removal in early bladder cancer
Compares heated and standard mitomycin-C treatment to reduce early bladder cancer return in adults.
Key facts
- Who runs it
- University Hospital Of Canary Islands
- Where
- San Cristobal De La Laguna, SpainSee the site
- Registry title
- PROSPECTIVE RANDOMISED CLINICAL TRIAL TO EVALUATE THE EARLY RECURRENCE RATE IN NON-MUSCLE INVASIVE BLADDER CANCER BETWEEN THE USE OF CHEMOHYPERTHERMIA (QH) WITH MITOMYCIN-C PRIOR TO TRANSURETHRAL BLADDER RESECTION IN A MAJOR OUTPATIENT SURGERY PROGRAMME AND TREATMENT WITH MITOMYCIN-C IN NORMOTHERMIA POST-RESECTION.
- Status
- Recruiting
- Phase
- Phase 4
- People taking part
- 152 people, planned
- Started
- 28 Nov 2024
- Planned end
- 31 Mar 2026
- Type of study
- Interventional
- Record updated
- 28 November 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with non-muscle invasive bladder cancer. It compares heated mitomycin-C before bladder tumour removal with mitomycin-C at normal temperature after removal.
- Age
- 18 years or older
- Sex
- All sexes can join.
- Disease stage
- Non-muscle invasive bladder cancer.
Where in Spain
- University Hospital Of Canary IslandsSan Cristobal De La Laguna, SpainTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Plain-language title
- Tests heated mitomycin-C before bladder tumor removal in early bladder cancerGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 9 November 2026.
- Record updated
- 28 November 2024